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Oligo(2’-0-alkylribonucleotides) have been developed recently as novel oligonucleotide analogues with properties that enhance their use as antisense 
probes. They possess high chemical stability and are resistant o hydrolysis by DNA- or RNA-specific nucleases. Many forms of oligo(2’-O- 
alkyhibonucleotides) hybrid& specifically and efficiently to complementary RNA sequences, forming stable duplexes that are not substrates for 
cleavage by RNase H. In combination with prosthetic reporter groups, such as biotin, DNP or fluorophores, oligo(Y-0-alkylribonucleotides) have 
important applications in a wide range of biochemical studies on RNA function and structure. 
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1. INTRODUCTION 
Oligo(Y-0-alkylribonucleotides) are analogues of oli- 
goribonucleotides in which all the 2’-hydroxyl groups 
are alkylated (see Fig. 1). A major consequence of the 
presence of an alkyl group at the ribose 2’-hydroxyl is 
that the resulting polymer becomes resistant o cleavage 
by alkali and by a wide range of RNA and DNA specific 
nucleases. This is mainly due to the effect of the alkyl 
group reducing the nucleophilic character of the 2’ oxy- 
gen. However, steric hindrance by the bulky alkyl group 
also helps to reduce cleavage of the adjacent 3-5 
phosphodiester bond. This becomes more pronounced 
for larger alkyl groups, as seen in the rate of digestion 
of oligo(2’-0-alkylribonucleotides) by phospho- 
diesterases with dual RNA/DNA cleavage specificities, 
such as nuclease Pl . Thus, oligo(Y-O-methylribonucle- 
otides) are cleaved more efficiently by nuclease Pl than 
the bulkier oligo(2’-0-{3,3-dimethylallyl}ribonucleo- 
tides) [l]. 
In addition to their increased resistance to degrada- 
tion, certain forms of oligo(2’-0-alkylribonucleotides) 
also hybridise more stably to complementary, unmodi- 
fied RNA sequences than do either DNA or RNA oli- 
gonucleotides [2,3]. This unique combination of chemi- 
cal robustness and efficient hybridisation makes poly- 
mers of 2’-0-alkyl RNA the reagents of choice for many 
antisense applications in biochemistry and molecular 
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biology where hybridisation to RNA target sequences 
is involved. In this minireview we will survey the prop- 
erties of oligo(2’-0-alkylribonucleotides) and illustrate 
how they can be used as antisense probes. 
2. SYNTHESIS OF OLIG0(2’-O-ALKYLRIBONU- 
CLEOTIDES) 
The first in vitro syntheses of oligo(2’-O-alkylribonu- 
cleotides) were made over twenty years ago and in- 
volved the enzymatic synthesis of 2’-O-methyl RNA 
homopolymers [4-6]. This was achieved following the 
unexpected discovery that the enzyme polynucleotide 
phosphorylase could polymerise the S-diphosphates of 
2’-0-methyhibonucleosides [4]. However, chemical syn- 
thesis of mixed sequence oligo(2’-O-methylribonucleo- 
tides) was first reported only in 1985, by Inoue et al., 
using phosphotriester chemistry [7], while in 1989, 
Sproat et al. reported synthesis of mixed sequence 
oligo(2’-0-methylribonucleotides) using the more effi- 
cient phosphoramidite procedure [8]. 
The 2’-O-methyl ether of RNA is a naturally occur- 
ring modification found in vivo at selected positions in 
tRNAs, mRNAs, rRNAs and snRNAs. Recently, fol- 
lowing the encouraging results obtained using oligo(2’- 
0-methylribonucleotides) as antisense probes, the syn- 
thesis of non-naturally occurring 2’-0-alkyl ethers of 
ribonucleosides has also been explored. This has in- 
cluded the synthesis of oligo(2’-0-allylribonucleotides) 
[1,9,10], oligo(2’-O-{3,3-dimethylallyl}ribonucleotides) 
[l], oligo(2’-0-butylribonucleotides) [l l] and oligo(2’- 
0-ethylribonucleotides) [ 12,131. The structures of these 
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analogues are illustrated in Fig. 1. Both the 2’-O-methyl 
and 2’-O-ally1 derivatives are now commercially availa- 
ble and the corresponding oligo(2’-O-methyl and 2’-O- 
allylribonucleotides) can be conveniently synthesised 
using the standard 2-cyanoethyl phosphoramidite 
chemistry that is routinely employed for DNA synthesis 
[14]. The only significant difference from the synthesis 
of DNA is that the coupling time for 2’-0-alkyl modi- 
fied ribonucleosides, using tetrazole as activator, must 
be extended to between 5 and 15 min, depending on the 
size of the 2’-0-alkyl group. 
Many important applications of oligo(Y-O-alkylribo- 
nucleotides) require the synthesis of probes containing 
prosthetic reporter groups, such as biotin, DNP or 
fluorophores. As will be discussed later, the presence of 
such reporter groups facilitates detection and allows the 
oligonucleotides, together with any other molecules in- 
teracting with them, to bind to specific affinity matrices. 
This forms the basis of several affinity chromatography 
methods that are useful for the purification, depletion 
and characterisation of RNA or RNA-protein com- 
plexes. Attachment of reporter groups can either be 
done post-synthetically, using an appropriate amino- 
linker [8], or, more conveniently, during the solid phase 
synthesis using commercially available reporter-linked 
phosphoramidites. 
3. HYBRIDISATION PROPERTIES OF OLIG0(2’- 
0-ALKYLRIBONUCLEOTIDES) 
The thermal stability of duplexes formed between 
oligo(2’-0-alkylribonucleotides) and complementary 
RNA target sequences i  of prime importance for their 
use as antisense probes. The development of chemical 
methods for synthesising 2’-0-alkylated polymers of de- 
fined sequence has allowed their hybridisation proper- 
ties to be analysed in detail. Inoue et al. showed that 
short oligo(Y-0-methylribonucleotides) formed hybrids 
with complementary, unmethylated oligoribonucleo- 
tides that were similar in stability to RNA-RNA ho- 
moduplexes and more stable than the corresponding 
DNA-RNA ones [2]. A separate study by Kibler-Her- 
zog et al., reported that a 14 mer 2’-O-methyl modified 
RNA oligonucleotide formed a more stable duplex with 
a complementary DNA strand than either unmodified 
RNA, unmodified DNA or phosphate-modified DNA, 
in the following order: 2’-O-methyl RNA > DNA > 
unmodified RNA > methylphosphonate DNA > phos- 
phorothioate DNA [3]. 
Our own thermal analyses of duplex stability (previ- 
ously unpublished data), comparing a variety of 
oligo(2’-0-alkylribonucleotides) as antisense probes 
(i.e. (-)strand), and a complementary oligoribonucleo- 
tide (sequence 5’-GAGGCUUAUCCA-3’) as the tar- 
get, (i.e. (+)strand), have led to the following order 
of stability, measured in 0.1 M salt solution at pH 
7.0: RNA.2’-O-methyl RNA (T, 61.8”C) > RNA*2’-O- 
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Fig. 1. The structure of an oligo(2’-O-alkylribonucleotide) n residues 
long is illustrated, in which R represents an alkyl group and B repre- 
sents any nucleobase, generally uracil-l-y1 (U), cytosin-l-y1 (C), 
adenin-9-yl (A) or guanin-9-yl (G). The following alkyl groups have 
been incorporated: -CH, (methyl) [7,8], -CH,CH, (ethyl) [12,13], - 
CH,CH=CH, (ally]) [1,9,10], CH,CH,CH,CH, (butyl) [ll], or - 
CH&H=C(CH& (3,3-dimethylallyl) [l]. 
ally1 RNA (T, 57.3”C) 2 RNAeRNA (T,,, 56.6”C) > 
RNA.2’-0-butyl RNA (T,,, 51 .S’C) > RNA*2’-O-di- 
methylallyl RNA (T,,, 46°C). 
The above data show clearly that the stability of 
RNA-2’-0-alkyl RNA heteroduplexes is dependent 
upon the structure of the 2’-0-alkyl group. However, 
the presence of modified bases, as well as sugars, can 
also influence the hybridisation properties of an antis- 
ense probe [15-191. An example of this is the incorpora- 
tion within oligo(Y-0-alkyhibonucleotides) of the mod- 
ified base 2,6-diaminopurine (i.e. 2aminoadenine), 
which forms three hydrogen bonds to uracil to give a 
base pair of similar stability to a GC pair. This increases 
the T,,, of the hybhid formed between an oligo(2’-O- 
alkylribonucleotide) antisense probe and an unmodified 
RNA target by approximately 3°C per 2-aminoadenine 
incorporated [ 171. The extra stabilisation conferred by 
2-aminoadenine can be especially valuable in allowing 
short probes to be used effectively against U-rich target 
sequences [15]. Another example of duplex stabilisation 
through incorporation of modified bases is provided by 
the recent demonstration by Froehler et al. that the 
presence of a 5-propynyl substituent on either 2’-O-ally1 
U, or 2’-O-ally1 C, in oligo(Y-0-allylribonucleotide) 
probes significantly increases the stability of hybrids 
with RNA targets; the increases in T, per substitution 
being 1.7”C @‘-O-ally1 U) and 2°C (2’-O-ally1 C) re- 
spectively [18]. The 5-propynyl U will therefore be par- 
ticularly useful for probes designed to hybridise with 
short, A-rich RNA targets. 
In summary, several studies have established that 
oligo(Y-0-alkylribonucleotides) with unbranched, 
short chain alkyl groups hybridise more stably to un- 
modified RNA than either DNA or RNA itself. The 
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physical basis for this enhanced duplex stability is at 
present unclear. However, it is interesting to compare 
the stabilizing effect of alkylating the ribose 2’ hydroxyl 
in RNA with the corresponding decrease in the stability 
of hybridisation observed when phosphorothioate 
groups are introduced into the backbone of DNA to 
make it resistant o nuclease degradation [3]. The alkyl 
groups in oligo(Z-O-alkylribonucleotides) also decrease 
their interaction with nucleic acid binding proteins [l]. 
In many biological experiments this serves to increase 
the fraction of the probe available for binding to target 
sequences by minimising the formation of non-specific 
protein-oligonucleotide complexes that cannot hy- 
bridise. It should also be noted that RNA target se- 
quences are not cleaved by RNase H when hybridised 
to oligo(2’Galkylribonucleotides) [20]: RNase H 
cleaves RNA specifically when it is hybridised to DNA 
[21]. This fortunate combination of properties, includ- 
ing stable hybrid formation, resistance to degradation 
and low non-specific interactions therefore makes 2’-O- 
alkyl RNA polymers well suited for use as antisense 
probes. 
4. APPLICATION OF OLIGO(Y-O-ALKYLRIBO- 
NUCLEOTIDES) AS ANTISENSE PROBES 
Antisense probes can be used either to block the func- 
tion of specific RNAs, or as affinity chromatography 
reagents for the depletion or purification of RNA or 
RNA-protein complexes. The stable in situ hybridisa- 
tion of an antisense probe labeled with a suitable re- 
porter group can also be used to detect RNAs in the 
fluorescence or electron microscope. Antisense probes 
thus provide important tools for studies on RNA bio- 
chemistry and gene expression and complement ech- 
niques based on the use of immunological reagents. We 
discuss below recent examples illustrating these applica- 
tions using antisense probes made of oligo(2’-O-alkylri- 
bonucleotides). 
Most of the initial applications of antisense oligo(2’- 
0-alkylribonucleotides) have been directed towards the 
study of RNA processing. One of the major RNA proc- 
essing reactions in eukaryotic cells is splicing, i.e. the 
removal of introns from mRNA precursors (pre- 
mRNA). Splicing takes place in the nucleus within a 
large RNA-protein complex termed the spliceosome 
[22]. The major subunits of the spliceosome are the Ul, 
U2, U4/U6 and U5 small nuclear ribonucleoprotein 
particles (snRNPs), each of which is itself an RNA- 
protein complex containing one (or two in the case of 
U4/U6) small nuclear RNAs (snRNAs) and snRNP 
proteins. Each of the snRNPs are essential for pre- 
mRNA splicing and their functions and structures how 
a high level of evolutionary conservation [23]. 
Antisense oligo(2’-O-methyl and 2’-O-allylribonucle- 
otides) that hybridise specifically to each of the splicing 
snRNAs have been developed [l&17,24-26]. In many 
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Fig. 2. The cartoon illustrates the general strategy for affinity chrom- 
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atography using antisense. probes. Here the antisense probe is an 
oligo(2’-O-alkylribonucleotide) linked to biotin (B), via a long, flexible 
spacer arm [25,26,40]. The antisense probe is complementary to an 
exposed RNA target sequence in the RNA-protein complex. In step 
1, a stable hybrid is formed specifically between the targeted RNA and 
antisense probe in an in vitro extract. In step 2, the biotin on the 
antisense probe is bound to an appropriate affinity matrix (e.g. strep- 
tavidin, avidin or anti-biotin antibodies coupled to agarose beads). 
This selectively retains both the biotinylated antisense probe and any 
other molecules tably bound to it. This strategy can be used either 
to purify and characterise the targeted RNA or RNA-protein complex 
(step 3) [25,26,28-321, or to efficiently remove the targeted complex, 
allowing subsequent analysis of the depleted extract (step 4) [15,35,36]. 
cases, binding of an antisense probe to an snRNA inhib- 
its splicing. The inhibitory effect can arise either because 
the antisense hybrid with the snRNA blocks the snRNP 
base pairing to pre-mRNA (i.e. competitive hybrid for- 
mation), or because it dissociates the snRNP (i.e. dis- 
ruptive hybrid formation). The binding of antisense 
probes to different regions of the snRNA in a snRNP 
particle can also inhibit different stages of the splicing 
reaction. For example, antisense probes binding to dif- 
ferent regions of U2 snRNA can specifically block ei- 
ther stable binding of U2 snRNP to pre-mRNA, the 
completion of spliceosome assembly after binding of U2 
snRNP or the conversion of splicing intermediates to 
products within the spliceosome [17]. Mayeda et al. 
have also shown that splicing can be inhibited in vitro 
by oligo(2’-0-methylribonucleotides) complementary 
to the splice sites in /3-globin pre-mRNA [27]. 
125 
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The U7 snRNP is not involved in splicing but instead 
is an essential factor in the 3’ processing reaction that 
forms the mature 3’ termini of histone mRNAs. Cotten 
et al. have shown that the 3’ end processing of histone 
pre-mRNA can be inhibited by antisense oligonucleo- 
tides made of oligo(2’-O-methyl or 2’-O-ethylribonucle- 
otides) that are complementary to U7 snRNA [12]. The 
same authors showed in addition that both forms of 
oligo@‘-0-alkylribonucleotides) were more potent in- 
hibitors of U7 snRNP function than either RNA or 
phosphorothioate modified DNA probes of identical 
sequence [ 121. 
The stable binding of antisense oligo(2’-O-alkylribo- 
nucleotide) probes containing reporter groups such as 
biotin has also been used to affinity purify or deplete 
snRNPs from in vitro extracts (illustrated in Fig. 2). 
Both nucleoplasmic snRNPs involved in splicing and 
nucleolar snRNPs involved in pre-t-RNA processing 
have been purified through hybridisation of biotinyl- 
ated antisense probes made of either oligo(2’-O-methyl 
or 2’-0-allylribonucleotides) [ 15,17,26,28]. Similarly, bi- 
otinylated oligo(Z-0-alkylribonucleotides) complemen- 
tary to pre-mRNA sequences have also been used to 
affinity select assembled spliceosomes [29]. Antisense 
affinity selection can purify snRNPs (or other RNPs) 
sufficiently for the associated proteins to be analysed 
directly [3&32]. This has been particularly useful for 
studies of snRNP proteins in trypanosome extracts, 
where no antibodies were available that would recog- 
nise the trypanosome snRNPs [31]. 
Other important applications of antisense affinity se- 
lection have emerged in recent studies where it was used 
to enrich for rare species prior to further analysis. For 
example, Bruzik and Maniatis have used biotinylated 
oligo(2’-U-methylribonucleotides) to enrich for RNAs 
that have undergone a trans-splicing reaction, which 
occurs at low frequency in mammalian cells [33]. The 
affinity enriched, trans-spliced RNAs could then be am- 
plified by the PCR method and characterised in detail. 
In a separate study, Wassarman and Steitz used bioti- 
nylated oligo(2’-0-methylribonucleotides) to enrich for 
specific snRNA complexes that had been cross-linked 
to pre-mRNA by treating splicing extracts with psor- 
alen [34]. The cross-linked complexes could then be 
analysed by two-dimensional polyacrylamide gel elec- 
trophoresis. 
The specificity and stability of hybrid formation be- 
tween oligo(2’-O-alkylribonucleotides) and RNA target 
sequences also facilitates high efficiency depletion of 
RNP complexes from cell-free extracts using the anti- 
sense approach. For example, the concentration of either 
the Ul, U2, U4/U6 or U5 snRNPs can be made rate 
limiting for splicing in vitro through antisense affinity 
depletion [15,35,36]. In the case of U5 snRNP, incorpo- 
ration of 2-aminoadenine in place of adenine in the 
antisense probe was important for high efficiency deple- 
tion, since the only complementary sequence in U5 
126 
snRNA available for hybridisation is a short, U-rich 
loop [15]. These depletion studies demonstrated that 
while each snRNP is essential for splicing, spliceosome 
assembly was arrested at different stages according to 
which snRNP was depleted. This confirms that there is 
a specific order of snRNP binding to pre-mRNA during 
spliceosome assembly. 
The nuclease resistance and favourable hybridisation 
properties of oligo(2’-0-alkyhibonucleotides) has also 
been exploited to localise RNAs in mammalian cells by 
in situ hybridisation [28,37-391. Antisense probes 
bound to RNA in situ can be visualised by fluorescence 
microscopy either through secondary labeling with 
avidin-conjugated fluorochromes, or directly through 
attachment of fluorochromes to the oligonucleotides. 
For example, nucleoplasmic and nucleolar snRNAs, 
and 5S and 28s rRNAs have been localised in this way 
[28,38,39]. Antisense oligo(Y-0-allylribonucleotides) 
coupled to fluorochromes have also been microinjected 
into living cells and thus used to localise RNAs in cells 
that have not been exposed to fixation procedures [37]. 
The distribution of different RNAs can also be com- 
pared in parallel by microinjecting specific oligonucleo- 
tides coupled to different fluorochromes [37]. 
In conclusion, the properties of oligo@‘-O-alkylribo- 
nucleotides) make them valuable reagents for use as 
antisense probes. Recent studies have established that 
they can be effectively used to inhibit RNA function, to 
purify or deplete RNAs or RNA-protein complexes 
and to determine RNA localisation patterns in situ. 
Now that phosphoramidites allowing the chemical syn- 
thesis of 2’-O-methyl and 2’-O-ally1 modified polymers 
are commercially available, we anticipate a significant 
increase in the use of oligo(2’Galkylribonucleotides) 
for a wide range of experiments in biochemistry and 
molecular biology that can benefit from the application 
of antisense techniques. 
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